How does 1VF0's PE Ratio compare to its peers?

1VF0 is expensive based on its Price-To-Earnings Ratio (33.7x) compared to the peer average (13.8x).

How does 1VF0's PE Ratio compare vs other companies in the European Pharmaceuticals Industry?

1VF0 is expensive based on its Price-To-Earnings Ratio (33.7x) compared to the European Pharmaceuticals industry average (22x).

What is 1VF0's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate 1VF0's Price-To-Earnings Fair Ratio for valuation analysis.

What is the Fair Price of 1VF0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate 1VF0's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

1VF0 Stock Overview

A craft cannabis company, focuses on premium flower and flower-derived products. More details

1VF0 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	4/6
Financial Health	5/6
Dividends	0/6

Rewards

Earnings grew by 188.5% over the past year

Risk Analysis

Shares are highly illiquid

High level of non-cash earnings

Latest financial reports are more than 6 months old

Shareholders have been diluted in the past year

My Notes

Capture your thoughts, links and company narrative

Grown Rogue International Inc. Competitors

MPH Health Care

DB:93M1

€98.5m

PharmaSGP Holding

XTRA:PSG

€318.9m

Dermapharm Holding

XTRA:DMP

€2.1b

2invest

XTRA:2INV

€69.0m

Price History & Performance

Summary of share price highs, lows and changes for Grown Rogue International
Historical stock prices
Current Share Price	CA$0.54
52 Week High	CA$0.56
52 Week Low	CA$0.54
Beta	0.070
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-2.08%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	1VF0	DE Pharmaceuticals	DE Market
7D	-0.6%	1.5%	1.9%
1Y	n/a	-7.6%	15.1%

Return vs Industry: Insufficient data to determine how 1VF0 performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 1VF0 performed against the German Market.

Price Volatility

Is 1VF0's price volatile compared to industry and market?
1VF0 volatility
1VF0 Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	5.3%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.3%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 1VF0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 1VF0's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1978	n/a	Jesse Strickler	www.grownrogue.com

Grown Rogue International Inc., a craft cannabis company, focuses on premium flower and flower-derived products. It produces a range of cultivars for consumers, which are classified as indicas, sativas, and hybrids. The company sells its products through dispensaries.

Grown Rogue International Inc. Fundamentals Summary

How do Grown Rogue International's earnings and revenue compare to its market cap?
1VF0 fundamental statistics
Market cap	€125.38m
Earnings (TTM)	€3.72m
Revenue (TTM)	€21.06m

33.7x

P/E Ratio

6.0x

P/S Ratio

Is 1VF0 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1VF0 income statement (TTM)
Revenue	US$21.83m
Cost of Revenue	US$7.60m
Gross Profit	US$14.22m
Other Expenses	US$10.37m
Earnings	US$3.86m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0.017
Gross Margin	65.17%
Net Profit Margin	17.67%
Debt/Equity Ratio	24.9%

How did 1VF0 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/02 07:35
End of Day Share Price	2025/01/31 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Grown Rogue International Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Siddharth Rajeev	Fundamental Research Corp.